112 related articles for article (PubMed ID: 35787339)
1. High-Mobility Group Box Protein 1 Is an Independent Prognostic Marker for All-Cause Mortality in Patients With Dilated Cardiomyopathy.
Kümmel A; Gross S; Feldtmann R; Chamling B; Strohbach A; Lehnert K; Bahls M; Loerzer L; Moormann K; Witte J; Riad A; Dörr M; Fielitz J; Felix SB
Am J Cardiol; 2022 Sep; 178():119-123. PubMed ID: 35787339
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
[TBL] [Abstract][Full Text] [Related]
3. Effect of Shenqi Yangxin decoction on high mobility group box 1 and inflammatory signal pathway in a rat model of dilated cardiomyopathy.
Shen L; Xing Q; Lu S; Zhou Y; Zhou C; Li L
J Tradit Chin Med; 2018 Dec; 38(6):862-871. PubMed ID: 32186133
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
6. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
9. [Value of N-terminal pro-B-type natriuretic peptide on long-term outcome of patients with hypertrophic cardiomyopathy].
Meng XB; Wang WY; Zhang K; Qi Y; An SM; Wang SY; Zheng JL; Yu QJ; Tang B; Wu R; Wang SY; Gao CY; Tang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):192-197. PubMed ID: 29562423
[No Abstract] [Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis.
Wei XB; Liu YH; He PC; Yu DQ; Zhou YL; Tan N; Chen JY
Eur J Prev Cardiol; 2017 May; 24(7):676-684. PubMed ID: 28067531
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
15. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
17. N-Terminal Pro-B-Type Natriuretic Peptide in Tricuspid Valve Replacement.
Cheng Y; Ou J; Tang B; Wang Q; Liang M; Wang Z; Wu Z
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):801-810. PubMed ID: 32473963
[TBL] [Abstract][Full Text] [Related]
18. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
19. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
Nasser N; Perles Z; Rein AJJT; Nir A
Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
[TBL] [Abstract][Full Text] [Related]
20. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level.
Kim H; Shin HW; Son J; Yoon HJ; Park HS; Cho YK; Han CD; Nam CW; Hur SH; Kim YN; Kim KB
Congest Heart Fail; 2010; 16(4):153-8. PubMed ID: 20662867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]